Categories: HealthcareNews

Teladoc Health is Providing Free Virtual Health Care Services to New Mexico Residents Impacted by Wildfires

PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) — Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, is providing free, 24/7 general medical telehealth visits to New Mexico residents, first responders and others directly impacted by the devastating wildfires.

Individuals in New Mexico who have been displaced or who cannot access medical care as a result of the fires can seek treatment from a licensed health care professional for any non-emergency illness by calling Teladoc Health directly at 855-225-5032. Individuals seeking physician-authorization for prescription refills of non-narcotic drugs can also get assistance. For emergencies, patients should call 911.

“We encourage those impacted by the fires to continue to prioritize their health and safety, especially as patients may experience wildfire-induced flare ups of chronic illnesses, such as asthma,” said Dr. Vidya Raman-Tangella, chief medical officer at Teladoc Health. “Virtual care is a proven solution that supports community health during these times, and we are grateful to provide access to care as New Mexico rebuilds and recovers from the fires.”

Among those adult and pediatric conditions that can be effectively diagnosed and treated as part of Teladoc Health’s general medical no-cost offering are common conditions including urinary tract infections, sinus problems, respiratory infections, allergies, cold and flu symptoms, and many other non-emergency illnesses.

Teladoc Health deploys resources each year to respond to federally declared natural disasters across the United States, making virtual care services available at no cost to communities impacted by floods, storms, fires and other public emergencies. For more information, visit https://www.teladochealth.com/info/disaster-hotline.

About Teladoc Health

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com.

Source: Teladoc Health, Inc. – General

Contact
Carolyn Edwards
PR@teladochealth.com
+1 321-795-1952

Staff

Recent Posts

Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

56 minutes ago

Functional Brands Inc. Launches Kirkman’s(R) Skin, Beauty & Anti-Aging Bundle: A Science-Backed Approach to Radiant, Resilient Skin

Comprehensive Formula Featuring Reduced Glutathione, Zinc Cream, Biotin, and Grapefruit Seed ExtractLake Oswego, Oregon--(Newsfile Corp.…

56 minutes ago

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces…

2 hours ago

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment…

3 hours ago

Black Book Poll: “Governed AI” Emerges as the Deciding Factor in 2026 NHS Procurement

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety…

3 hours ago

Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the…

3 hours ago